The molecular explanation about why some pancreatic cancer (PaCa) patients die early and
others die later is poorly understood. This study aimed to discover potential novel markers …

Background: Pancreatic ductal adenocarcinoma (PDAC) is formidable in its advanced,
metastatic stage. Aggressive spread of malignant cells from the pancreas to distant organs …

Background Effective prognostic assessment and appropriate drug selection are important
for the clinical management of pancreatic cancer (PaC). Here, we aimed to establish a …

Objective Pancreatic ductal adenocarcinoma (PDAC) has high mortality and poor prognosis.
Pyroptosis can influence the prognosis of patients by regulating the proliferation, invasion …

Background Pancreatic adenocarcinoma (PAAD) is one of the most common malignant
tumors of the digestive tract. Pyroptosis is a newly discovered programmed cell death that …

Background Although genes have been previously detected in pancreatic cancer (PC),
aberrant genes that play roles in resectable pancreatic cancer should be further assessed …

Background Although some improvements in the management of pancreatic cancer (PC)
have been made, no major breakthroughs in terms of biomarker discovery or effective …

Objective: To probe into the role of pyroptosis-related genes in pancreatic carcinoma.
Methods: Herein, we conducted a comprehensive bioinformatics analysis to evaluate tumor …

Background Pancreatic carcinoma (PC) is one of the most aggressive cancers affecting
human health. It is essential to identify candidate biomarkers for the diagnosis and …

Recent studies have indicated that pyroptosis may participate in the regulation of
tumorigenesis and immune microenvironment. However, the role of pyroptosis-related …